Stay updated on PAAP for Pralsetinib in NSCLC and MTC Clinical Trial

Sign up to get notified when there's something new on the PAAP for Pralsetinib in NSCLC and MTC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PAAP for Pralsetinib in NSCLC and MTC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.2 to v3.5.3, indicating a minor version change to the site display rather than a change to the clinical trial content.
    Difference
    0.1%
    Check dated 2026-04-24T05:55:15.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:25:16.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    Medullary thyroid carcinoma is now listed as a condition, and the Genetic and Rare Diseases Information Center has been added to the Resources section.
    Difference
    0.2%
    Check dated 2026-04-02T15:14:42.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Revision updated to v3.5.0, replacing v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T04:43:47.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    Revision: v3.4.3 is shown instead of v3.4.2. There are no visible changes to the study information or user actions on the page.
    Difference
    0.1%
    Check dated 2026-03-12T00:00:38.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the funding-status notice and the previous Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2026-02-11T14:11:21.000Z thumbnail image

Stay in the know with updates to PAAP for Pralsetinib in NSCLC and MTC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PAAP for Pralsetinib in NSCLC and MTC Clinical Trial page.